Cumberland Pharmaceuticals Inc (CPIX)
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-11-04
$5.01+12.84%
Close 2026-11-05 · 1-day change
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-11-04
QuarterlyIQ Insights · CPIX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 31.3 | 44.5 | 37.9 | 39.6 | 42.0 | 36.0 | 37.4 | 34.4 | 29.3 | 26.3 | 33.0 | 0.9 | 0.6 | 32.0 | 48.9 | 51.1 |
| Total Revenues | — | — | — | — | 42.0 | 36.0 | 37.4 | 34.4 | 29.3 | 26.3 | 33.0 | 0.9 | 0.6 | 32.0 | 48.9 | 51.1 |
| Cost of Revenues | — | 6.7 | 6.6 | 6.1 | 9.1 | 8.8 | 8.7 | 7.4 | 6.0 | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 5.7 | 5.6 | 4.8 | 5.8 | 6.7 | 5.7 | 5.8 | 6.9 | 7.6 | 4.2 | 3.2 | 3.8 | 3.4 | 5.6 | 5.1 | 5.0 |
| Operating Income | (9.6) | (2.8) | (6.4) | (9.6) | (5.7) | (7.7) | (6.4) | (9.3) | (11.2) | (8.9) | (1.4) | 1.1 | 3.6 | (3.8) | 8.8 | 9.8 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | 0.4 | 0.5 | 0.6 | 0.7 | 0.6 | 0.1 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.4 |
| Interest & Investment Income | 0.4 | 0.5 | 0.3 | 0.3 | 0.1 | 0.0 | 0.1 | 0.2 | 0.6 | 0.3 | 0.2 | 0.2 | 0.3 | 0.2 | 0.3 | 0.2 |
| Net Interest Expenses | — | — | — | 0.4 | 0.5 | 0.1 | 0.2 | 0.0 | (0.4) | (0.2) | (0.1) | (0.1) | (0.2) | (0.1) | (0.2) | 0.1 |
| Asset Writedown | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | — |
| EBT, Incl. Unusual Items | — | (2.8) | (6.5) | (6.3) | (5.6) | (5.6) | (6.6) | (9.3) | (10.8) | (8.7) | (1.3) | 1.2 | 3.7 | (3.7) | 9.1 | 9.7 |
| Income Tax Expense | 0.0 | 0.0 | (0.0) | 0.0 | 0.1 | 0.0 | 0.1 | (0.1) | 0.0 | 4.2 | (0.3) | 0.6 | 1.4 | (1.5) | 3.2 | 4.1 |
| Earnings from Continuing Operations | — | (2.9) | (6.4) | (6.3) | (5.7) | (5.6) | (6.6) | — | — | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Minority Interest | (0.0) | (0.0) | 0.0 | (0.1) | (0.1) | (0.1) | (0.1) | (0.0) | (0.1) | (0.1) | (0.1) | (0.1) | (0.1) | (0.0) | (0.0) | (0.0) |
| Net Income | (10.9) | (2.8) | (6.5) | (6.3) | (5.6) | (3.5) | (3.3) | (3.5) | (7.0) | (8.0) | (0.9) | 0.7 | 2.4 | (2.1) | 5.8 | 5.7 |
| Per Share | ||||||||||||||||
| Basic EPS | (0.73) | (0.19) | (0.46) | (0.44) | (0.38) | (0.24) | (0.22) | (0.23) | (0.45) | (0.50) | (0.06) | 0.04 | 0.14 | (0.11) | 0.30 | 0.28 |
| Diluted EPS | (0.73) | (0.19) | (0.46) | (0.44) | (0.38) | (0.24) | (0.22) | (0.23) | (0.45) | (0.50) | (0.06) | 0.04 | 0.14 | (0.11) | 0.30 | 0.28 |
| Revenue per Share | 2.09 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 15.0 | 14.9 | 14.1 | 14.3 | 14.6 | 14.9 | 15.2 | 15.4 | 15.6 | 15.9 | 16.2 | 16.7 | 17.6 | 18.3 | 19.6 | 20.3 |
| Diluted Weighted Avg Shares | 15.0 | 14.9 | 14.1 | 14.3 | 14.6 | 14.9 | 15.2 | 15.4 | 15.6 | 15.9 | 16.2 | 17.1 | 17.9 | 18.3 | 19.8 | 20.6 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 1.4 | (1.5) | (4.6) | (0.4) | (3.1) | (1.6) | (4.9) | (8.2) | (6.2) | 1.0 | 3.4 | 5.5 | (2.5) | 9.7 | 10.9 |
| EBIT | (9.6) | (2.8) | (6.4) | (9.6) | (5.7) | (7.7) | (6.4) | (9.3) | (11.2) | (8.9) | (1.4) | 1.1 | 3.6 | (3.8) | 8.8 | 9.8 |
| Effective Tax Rate | — | — | — | -0.7% | -1.2% | -0.6% | -0.9% | 0.9% | -0.2% | -48.1% | 24.8% | 46.2% | 36.9% | 41.4% | 35.8% | 42.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.